Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1995 Mar;72(2):F139–F144. doi: 10.1136/fn.72.2.f139

Hypertension in pregnancy.

E M Symonds 1
PMCID: PMC2528384  PMID: 7712276

Full text

PDF
F139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arngrimsson R., Björnsson S., Geirsson R. T., Björnsson H., Walker J. J., Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol. 1990 Sep;97(9):762–769. doi: 10.1111/j.1471-0528.1990.tb02569.x. [DOI] [PubMed] [Google Scholar]
  2. Baker P. N., Broughton Pipkin F., Symonds E. M. Comparative study of platelet angiotensin II binding and the angiotensin II sensitivity test as predictors of pregnancy-induced hypertension. Clin Sci (Lond) 1992 Jul;83(1):89–95. doi: 10.1042/cs0830089. [DOI] [PubMed] [Google Scholar]
  3. Beaufils M., Uzan S., Donsimoni R., Colau J. C. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet. 1985 Apr 13;1(8433):840–842. doi: 10.1016/s0140-6736(85)92207-x. [DOI] [PubMed] [Google Scholar]
  4. Broughton Pipkin F., Symonds E. M., Turner S. R. The effect of captopril (SQ14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. J Physiol. 1982 Feb;323:415–422. doi: 10.1113/jphysiol.1982.sp014081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Campbell D. M., MacGillivray I., Carr-Hill R. Pre-eclampsia in second pregnancy. Br J Obstet Gynaecol. 1985 Feb;92(2):131–140. doi: 10.1111/j.1471-0528.1985.tb01064.x. [DOI] [PubMed] [Google Scholar]
  6. Campbell D. M., MacGillivray I., Thompson B. Twin zygosity and pre-eclampsia. Lancet. 1977 Jul 9;2(8028):97–97. doi: 10.1016/s0140-6736(77)90109-x. [DOI] [PubMed] [Google Scholar]
  7. Chesley L. C., Cooper D. W. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol. 1986 Sep;93(9):898–908. doi: 10.1111/j.1471-0528.1986.tb08006.x. [DOI] [PubMed] [Google Scholar]
  8. Duffus G. M., MacGillivray I. The incidence of pre-eclamptic toxaemia in smokers and non-smokers. Lancet. 1968 May 11;1(7550):994–995. doi: 10.1016/s0140-6736(68)91106-9. [DOI] [PubMed] [Google Scholar]
  9. Filshie G. M., Maynard P., Hutter C., Cooper J. C., Robinson G., Rubin P. Urinary 5-hydroxyindole acetate concentration in pregnancy induced hypertension. BMJ. 1992 May 9;304(6836):1223–1223. doi: 10.1136/bmj.304.6836.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hayward C., Livingstone J., Holloway S., Liston W. A., Brock D. J. An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance. Am J Hum Genet. 1992 Apr;50(4):749–757. [PMC free article] [PubMed] [Google Scholar]
  11. Howie P. W., Prentice C. R., McNicol G. P. Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J Obstet Gynaecol Br Commonw. 1971 Nov;78(11):992–1003. doi: 10.1111/j.1471-0528.1971.tb00216.x. [DOI] [PubMed] [Google Scholar]
  12. Kovatz S., Arber I., Korzets Z., Rathaus M., Ben Aderet N., Bernheim J. Urinary kallikrein in normal pregnancy, pregnancy with hypertension, and toxemia. Nephron. 1985;40(1):48–51. doi: 10.1159/000183426. [DOI] [PubMed] [Google Scholar]
  13. McKillop C. A., Howie P. W., Forbes C. D., Prentice C. R. Sequential studies in pre-eclampsia using plasma fibrinogen chromatography. Br J Obstet Gynaecol. 1977 Dec;84(12):909–918. doi: 10.1111/j.1471-0528.1977.tb12520.x. [DOI] [PubMed] [Google Scholar]
  14. Need J. A. Pre-eclampsia in pregnancies by different fathers: immunological studies. Br Med J. 1975 Mar 8;1(5957):548–549. doi: 10.1136/bmj.1.5957.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pritchard J. A., Cunningham F. G., Mason R. A. Coagulation changes in eclampsia: their frequency and pathogenesis. Am J Obstet Gynecol. 1976 Apr 15;124(8):855–864. doi: 10.1016/s0002-9378(16)33390-7. [DOI] [PubMed] [Google Scholar]
  16. Rákóczi I., Tallián F., Bagdány S., Gáti I. Platelet life-span in normal pregnancy and pre-eclampsia as determined by a non-radioisotope technique. Thromb Res. 1979;15(3-4):553–556. doi: 10.1016/0049-3848(79)90161-0. [DOI] [PubMed] [Google Scholar]
  17. Stainer K., Pickles C., Cowley A. J. The effects of posture on abnormalities of forearm venous tone in women with pregnancy-induced hypertension. Clin Sci (Lond) 1987 Sep;73(3):267–269. doi: 10.1042/cs0730267. [DOI] [PubMed] [Google Scholar]
  18. Stevenson A. C., Davison B. C., Say B., Ustuoplu S., Liya D., Abul-Einen M., Toppozada H. K. Contribution of fetal/maternal incompatibility to aetiology of pre-eclamptic toxaemia. Lancet. 1971 Dec 11;2(7737):1286–1289. doi: 10.1016/s0140-6736(71)90604-0. [DOI] [PubMed] [Google Scholar]
  19. Stubbs T. M., Lazarchick J., Horger E. O., 3rd Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol. 1984 Dec 1;150(7):885–887. doi: 10.1016/0002-9378(84)90468-x. [DOI] [PubMed] [Google Scholar]
  20. Symonds E. M., Stanley M. A., Skinner S. L. Production of renin by in vitro cultures of human chorion and uterine muscle. Nature. 1968 Mar 23;217(5134):1152–1153. doi: 10.1038/2171152a0. [DOI] [PubMed] [Google Scholar]
  21. Valdés G., Espinoza P., Moore R., Croxatto H. R. Urinary kallikrein and plasma renin activity in normal human pregnancy. Hypertension. 1981 Nov-Dec;3(6 Pt 2):II–55-8. doi: 10.1161/01.hyp.3.6_pt_2.ii-55. [DOI] [PubMed] [Google Scholar]
  22. Wallenburg H. C., Dekker G. A., Makovitz J. W., Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet. 1986 Jan 4;1(8471):1–3. doi: 10.1016/s0140-6736(86)91891-x. [DOI] [PubMed] [Google Scholar]
  23. Wallenburg H. C., Rotmans N. Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol. 1987 Nov;157(5):1230–1235. doi: 10.1016/s0002-9378(87)80300-9. [DOI] [PubMed] [Google Scholar]
  24. Walters B. N., Redman C. W. Treatment of severe pregnancy-associated hypertension with the calcium antagonist nifedipine. Br J Obstet Gynaecol. 1984 Apr;91(4):330–336. doi: 10.1111/j.1471-0528.1984.tb05918.x. [DOI] [PubMed] [Google Scholar]
  25. Ward K., Hata A., Jeunemaitre X., Helin C., Nelson L., Namikawa C., Farrington P. F., Ogasawara M., Suzumori K., Tomoda S. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 1993 May;4(1):59–61. doi: 10.1038/ng0593-59. [DOI] [PubMed] [Google Scholar]
  26. Weiner C. P., Brandt J. Plasma antithrombin III activity: an aid in the diagnosis of preeclampsia-eclampsia. Am J Obstet Gynecol. 1982 Feb 1;142(3):275–281. doi: 10.1016/0002-9378(82)90730-x. [DOI] [PubMed] [Google Scholar]
  27. Ylikorkala O., Mäkilä U. M., Käpä P., Viinikka L. Maternal ingestion of acetylsalicylic acid inhibits fetal and neonatal prostacyclin and thromboxane in humans. Am J Obstet Gynecol. 1986 Aug;155(2):345–349. doi: 10.1016/0002-9378(86)90823-9. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES